0001562180-22-008416.txt : 20221222
0001562180-22-008416.hdr.sgml : 20221222
20221222160500
ACCESSION NUMBER: 0001562180-22-008416
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221221
FILED AS OF DATE: 20221222
DATE AS OF CHANGE: 20221222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chardonnet Laurent
CENTRAL INDEX KEY: 0001329010
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39527
FILM NUMBER: 221481995
MAIL ADDRESS:
STREET 1: C/O AXCELLA HEALTH INC.
STREET 2: 840 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Prelude Therapeutics Inc
CENTRAL INDEX KEY: 0001678660
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811384762
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 POWDER MILL ROAD
CITY: WILMINGTON
STATE: DE
ZIP: 19803
BUSINESS PHONE: (302) 547-3768
MAIL ADDRESS:
STREET 1: 200 POWDER MILL ROAD
CITY: WILMINGTON
STATE: DE
ZIP: 19803
FORMER COMPANY:
FORMER CONFORMED NAME: Prelude Therapeutics Inc.
DATE OF NAME CHANGE: 20160630
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2022-12-21
false
0001678660
Prelude Therapeutics Inc
PRLD
0001329010
Chardonnet Laurent
C/O PRELUDE THERAPEUTICS INCORPORATED
200 POWDER MILL ROAD
WILMINGTON
DE
19801
false
true
false
false
Chief Financial Officer
Employee Stock Option (right to buy)
4.90
2022-12-21
4
A
false
75000.00
0.00
A
2032-12-20
Common Stock
75000.00
75000.00
D
The stock option vests as to 25% of the total shares on December 21, 2023, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
/s/ Laurent Chardonnet
2022-12-22